Amarin reported $1.82M in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Aerie Pharmaceuticals AERI:US $ -30.76M 0.92M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amarin AMRN:US $ 1.82M 7.74M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
AstraZeneca AZN:LN 2784M 588M
Epizyme EPZM:US $ -62.82M 6.9M
Esperion Therapeutics ESPR:US $ -55592000 23.21M
GlaxoSmithKline GSK:LN 3660M 1034M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Novartis NOVN:VX SF 4837M 65M
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M